One bioreactor that handles both seed expansion and high-density production reduces facility capital, simplifies qualification, and compresses the seed train. Turndown ratio is the specification that makes it possible.
Explore the principles, technologies, and applications that enable scientists to design and build DNA for research, biotechnology, and therapeutic development.
The field has invested heavily in building better models for antibody discovery. The structural interaction data those models are trained on has not kept pace — and that shortfall is now a defining constraint on what AI can reliably do.
The integrated workflow combines icIEF fractionation and mass photometry, enabling simultaneous assessment of charge and size variants at single molecule resolution .
SLAS Europe 2026 showcased growing realism around AI in drug discovery, with attention shifting toward data quality, interoperability, and lab execution.
Learn the key assay design principles and workflow considerations that help support robust, scalable, and reliable high-throughput screening campaigns.
Philip Wills, Chief Commercial Officer of the Cell & Gene Therapy Division at Catalent, reflects on how the gene therapy industry is evolving from early scientific breakthroughs to commercial maturity.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.